Nebraska § 71-9603 Eligible patient

Nebraska Statutes

§ 71-9603 — Eligible patient

Nebraska § 71-9603

Ch. 71Public Health and Welfare

This text of Nebraska § 71-9603 (Eligible patient) is published on Counsel Stack Legal Research, covering Nebraska primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Neb. Rev. Stat. § 71-9603 (2026).

Text

To be an eligible patient under the Investigational Drug Use Act, a person shall:

(1)Have an advanced illness, attested by the person's treating physician;

(2)Have considered all other treatment options approved by the United States Food and Drug Administration at the time;

(3)Have a recommendation from his or her treating physician for an investigational drug, biological product, or device;

(4)Give written, informed consent for the use of the investigational drug, biological product, or device;

(5)Have documentation from his or her treating physician that he or she meets the requirements of the act; and

(6)Not be a patient receiving inpatient treatment in a hospital licensed pursuant to the Health Care Facility Licensure Act.

Free access — add to your briefcase to read the full text and ask questions with AI

To be an eligible patient under the Investigational Drug Use Act, a person shall:
(1) Have an advanced illness, attested by the person's treating physician;
(2) Have considered all other treatment options approved by the United States Food and Drug Administration at the time;
(3) Have a recommendation from his or her treating physician for an investigational drug, biological product, or device;
(4) Give written, informed consent for the use of the investigational drug, biological product, or device;
(5) Have documentation from his or her treating physician that he or she meets the requirements of the act; and
(6) Not be a patient receiving inpatient treatment in a hospital licensed pursuant to the Health Care Facility Licensure Act.